在F3中的人类误解变体损害了血液凝结的启动
Shabbir A Ansari1, Marisa A Brake1, Nishtha Pathak2
1Beth Israel Deaconess Medical Center and Harvard Medical School, United States.
Blood
|October 16, 2025
概括
F3基因的罕见变异通过影响组织因子 (TF) 功能,显著影响血液凝固. 这些遗传变化可能会损害关键凝血因子的激活,影响整体血静.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 血液学 血液学 血液学
背景情况:
- 由F3编码的组织因子 (TF) 通过结合因子VII/VIIa启动血液凝结.
- 标准的临床试验并不能直接测量内源性TF,因此F3变异对凝血的影响尚不清楚.
研究的目的:
- 为了研究常见和罕见的人类TF误解变体对血液凝固的影响.
- 确定影响TF在启动凝血中的作用的变异,特别是在预计会扰乱该过程的部位.
主要方法:
- 分析高频率和罕见的TF误解变体.
- 评估TF启动的血凝固时间和因子IX/X激活.
- 关于因子VII自动激活和TF-因子VIIa相互作用的体外研究.
主要成果:
- 常见的F3变种没有影响凝血激活.
- 罕见的TF误解替代物通过两个机制对凝血时间和因子激活产生了深远的影响:受损的TF-因子VIIa结合或改变的TF外位功能.
- 该p.Gly196Arg变体降低了因子VIIa-抗组复合物和D-二聚合物水平,在体外自激活因子VII的功能受损.
结论:
- 在F3中罕见的误解变异可以显著损害因子VII,IX和X的激活.
- 这些变异表明它们在减少人类基本血液凝固激活中的作用.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
Extrinsic and Intrinsic Pathways of Hemostasis
12.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.0K
Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
Clot Retraction and Fibrinolysis
8.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.4K
Nonsense-mediated mRNA Decay
11.7K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.7K
Alternative RNA Splicing
24.7K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
24.7K


